World Journal of Surgery

, Volume 31, Issue 5, pp 924–933 | Cite as

An Evidence-based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow-up

  • Rebecca S. Sippel
  • Nadine R. Caron
  • Orlo H. Clark
Article

Abstract

Approximately 5% of nonmedullary thyroid cancers are of familial origin. When two or more family members are diagnosed with nonmedullary thyroid cancer in the absence of other known associated syndromes it is termed familial nonmedullary thyroid cancer (FNMTC). The genetic inheritance of FNMTC remains unknown, but it is believed to be an autosomal dominant mode of inheritance with incomplete penetrance and variable expressivity. FNMTC has been shown to be more aggressive and to have a worse prognosis than sporadic nonmedullary thyroid cancer. For example, studies have demonstrated that individuals with FNMTC have an increased risk of multifocal disease, local invasion, and lymph node metastases. These aggressive features appear to contribute to the higher recurrence rate and decreased disease-free survival seen in FNMTC patients compared to those with sporadic differentiated thyroid cancer. This article is an overview of the literature available in the English language discussing FNMTC. Critical questions regarding the screening, management, and follow-up of these patients are addressed with answers proposed based on the available literature. The quality of the evidence is ranked according to Sackett’s criteria. Overall, the literature quality is somewhat limited, based on the low prevalence of FNMTC, the difficulty in identifying familial cases, the variable study designs, and limited long-term follow-up. Conclusions: To date, the optimal clinical approach is yet to be established, but improved awareness and screening will permit earlier detection, more timely intervention, and hopefully improved outcomes for patients and their families.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130CrossRefPubMedGoogle Scholar
  2. 2.
    Loh KC. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 1997;7:107–113CrossRefPubMedGoogle Scholar
  3. 3.
    Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer 2003;103:105–109CrossRefPubMedGoogle Scholar
  4. 4.
    Alsanea O, Clark OH. Familial thyroid cancer. Curr Opin Oncol 2001;13:44–51CrossRefPubMedGoogle Scholar
  5. 5.
    Fischer DK, Groves MD, Thomas SJ Jr, et al. Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest 1989;7:323–325CrossRefPubMedGoogle Scholar
  6. 6.
    Stoffer SS, Van Dyke DL, Bach JV, et al. Familial papillary carcinoma of the thyroid. Am J Med Genet 1986;25:775–782CrossRefPubMedGoogle Scholar
  7. 7.
    Pal T, Vogl FD, Chappuis PO, et al. Increased risk for nonmedullary thyroid cancer in the first-degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 2001;86:5307–5312CrossRefPubMedGoogle Scholar
  8. 8.
    Grossman RF, Tu SH, Duh QY, et al. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 1995;130:892–897; discussion 898–899PubMedGoogle Scholar
  9. 9.
    Uchino S, Noguchi S, Kawamoto H, et al. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 2002;26:897–902CrossRefPubMedGoogle Scholar
  10. 10.
    Kwok CG, McDougall IR. Familial differentiated carcinoma of the thyroid: report of five pairs of siblings. Thyroid 1995;5:395–397CrossRefPubMedGoogle Scholar
  11. 11.
    Robinson D, Orr T. Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Arch Surg 1955;70:923–928Google Scholar
  12. 12.
    Goldgar DE, Easton DF, Cannon-Albright LA, et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600–1608CrossRefPubMedGoogle Scholar
  13. 13.
    Ron E, Kleinerman RA, LiVolsi VA, et al. Familial nonmedullary thyroid cancer. Oncology 1991;48:309–311CrossRefPubMedGoogle Scholar
  14. 14.
    Charkes ND. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 2006;16:181–186CrossRefPubMedGoogle Scholar
  15. 15.
    Charkes ND. On the prevalence of familial nonmedullary thyroid cancer. Thyroid 1998;8:857–858CrossRefPubMedGoogle Scholar
  16. 16.
    Triponez F, Wong M, Sturgeon C, et al. Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 2006;30:787–793CrossRefPubMedGoogle Scholar
  17. 17.
    Maxwell EL, Hall FT, Freeman JL. Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 2004;114:2182–2186CrossRefPubMedGoogle Scholar
  18. 18.
    Canzian F, Amati P, Harach HR, et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998;63:1743–1748CrossRefPubMedGoogle Scholar
  19. 19.
    Cetta F, Montalto G, Gori M, et al. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 2000;85:286–292CrossRefPubMedGoogle Scholar
  20. 20.
    Sturgeon C, Clark OH. Familial nonmedullary thyroid cancer. Thyroid 2005;15:588–593CrossRefPubMedGoogle Scholar
  21. 21.
    Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005;90:5747–5753CrossRefPubMedGoogle Scholar
  22. 22.
    Brunaud L, Zarnegar R, Wada N, et al. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Thyroid 2003;13:621–629CrossRefPubMedGoogle Scholar
  23. 23.
    Burgess JR, Duffield A, Wilkinson SJ, et al. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 1997;82:345–348CrossRefPubMedGoogle Scholar
  24. 24.
    Lupoli G, Vitale G, Caraglia M, et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 1999;353:637–639CrossRefPubMedGoogle Scholar
  25. 25.
    Musholt TJ, Musholt PB, Petrich T, et al. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 2000;24:1409–1417CrossRefPubMedGoogle Scholar
  26. 26.
    Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95(2 Suppl):2S–4SCrossRefPubMedGoogle Scholar
  27. 27.
    Segal K, Friedental R, Lubin E, et al. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 1995;113:356–363CrossRefPubMedGoogle Scholar
  28. 28.
    DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414–424CrossRefPubMedGoogle Scholar
  29. 29.
    McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978–996PubMedGoogle Scholar
  30. 30.
    Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 2000;290:138–1341CrossRefPubMedGoogle Scholar
  31. 31.
    Houlston RS, Stratton MR. Genetics of non-medullary thyroid cancer. Q J Med 1995;88:685–693Google Scholar
  32. 32.
    Alsanea O, Wada N, Ain K, et al. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 2000;128:1043–1050; discussion 1050–1051CrossRefPubMedGoogle Scholar
  33. 33.
    Miura D, Wada N, Chin K, et al. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization. Thyroid 2003;13:283–290CrossRefPubMedGoogle Scholar
  34. 34.
    Nishiyama RH. Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol 1999;6:281–286CrossRefPubMedGoogle Scholar
  35. 35.
    Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583–595CrossRefPubMedGoogle Scholar
  36. 36.
    Bevan S, Pal T, Greenberg CR, et al. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 2001;86:3701–3704CrossRefPubMedGoogle Scholar
  37. 37.
    Tucker MA, Boice JD Jr, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985;68:161–189PubMedGoogle Scholar
  38. 38.
    Uchino S, Noguchi S, Yamashita H, et al. Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg 2004;28:1099–1102CrossRefPubMedGoogle Scholar
  39. 39.
    Takami H, Ozaki O, Ito K. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Arch Surg 1996;131:676PubMedGoogle Scholar
  40. 40.
    Leprat F, Bonichon F, Guyot M, et al. Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clin Endocrinol (Oxf) 1999;50:589–594CrossRefGoogle Scholar
  41. 41.
    Vriens MR, Sabanci U, Epstein HD, et al. Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer. Thyroid 1999;9:1011–1016CrossRefPubMedGoogle Scholar
  42. 42.
    Bignell GR, Canzian F, Shayeghi M, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 1997;61:1123–1130CrossRefPubMedGoogle Scholar
  43. 43.
    McKay JD, Lesueur F, Jonard L, et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001;69:440–446CrossRefPubMedGoogle Scholar
  44. 44.
    Learoyd DL, Messina M, Zedenius J, et al. Molecular genetics of thyroid tumors and surgical decision-making. World J Surg 2000;24:923–933CrossRefPubMedGoogle Scholar
  45. 45.
    Malchoff CD, Sarfarazi M, Tendler B, et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000;85:1758–1764CrossRefPubMedGoogle Scholar
  46. 46.
    Lesueur F, Stark M, Tocco T, et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 1999;84:2157–2162CrossRefGoogle Scholar
  47. 47.
    Xing M. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol (Oxf) 2005;63:263–266CrossRefGoogle Scholar
  48. 48.
    Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14:315–332PubMedGoogle Scholar
  49. 49.
    Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:545–576PubMedGoogle Scholar
  50. 50.
    Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419–425CrossRefPubMedGoogle Scholar
  51. 51.
    Skinner MA, Moley JA, Dilley WG, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005;353:1105–1113CrossRefPubMedGoogle Scholar
  52. 52.
    Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003;349:1517–1525CrossRefPubMedGoogle Scholar
  53. 53.
    Zarnegar R, Brunaud L, Clark OH. Prevention, evaluation, and management of complications following thyroidectomy for thyroid carcinoma. Endocrinol Metab Clin North Am 2003;32:483–502CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2007

Authors and Affiliations

  • Rebecca S. Sippel
    • 1
  • Nadine R. Caron
    • 2
  • Orlo H. Clark
    • 1
  1. 1.University of California San Francisco Department of Surgery, UCSF Comprehensive Cancer Center at Mount ZionSan FranciscoCalifornia
  2. 2.Northern Medical Group, University of Northern British ColumbiaPrince GeorgeCanada

Personalised recommendations